Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002281838 | SCV002572348 | uncertain significance | not specified | 2022-08-25 | criteria provided, single submitter | clinical testing | Variant summary: FREM2 c.9019C>T (p.Arg3007X) is located in the last exon and results in a premature termination codon, predicted to cause a truncation of the encoded protein. The variant was absent in 251152 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.9019C>T in individuals affected with Cryptophthalmos Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Revvity Omics, |
RCV003138151 | SCV003828375 | uncertain significance | not provided | 2022-06-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005008516 | SCV005634430 | likely pathogenic | Isolated cryptophthalmia; Fraser syndrome 2 | 2024-04-27 | criteria provided, single submitter | clinical testing |